HSBC Holdings’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

HSBC Holdings’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-367,131	Closed	-$17M	–	2923
2023 Q2	$17M	Buy	+367,131	New	+$12.7M	0.02%	663

HSBC Holdings's DICE Position: Q3 2023 in Review

HSBC Holdings sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 367,131 shares — an estimated $17M sold.

HSBC Holdings first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $17M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

HSBC Holdings reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HSBC Holdings sold 367,131 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $17M.
HSBC Holdings first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
HSBC Holdings's DICE Therapeutics, Inc. Common Stock position peaked at $17M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.